Rezultati pretraživanja
  1. prije 26 minuta

    MADHARA YAPI YA DAWA NITAYARIPOTI/ SHITAKI Usikae kimya ripoti madhara/maudhi YOTE mabaya yanayotokana na Dawa unazotumia 1. Yanajulikana au hayajulikani 2. Makubwa au Madogo 3. Yamewahi kutokea au hayajawahi 4. Yanakutesa sana au kawaida

  2. prije 2 sata

    IKUMBUKWE Sio kila mgonjwa alie na hali mbaya ni kwa sababu ya ugonjwa alionao, Wengine hali hua mbaya zaidi kutokana na madhara ya dawa wanazotumia ONGEA/SHITAKI Usikae kimya endapo dawa unazotumia zinaleta maudhi/madhara usiyoyaelewa👇

    Prikaži ovu nit
  3. prije 2 sata

    JE WAJUA Dawa zina madhara ambayo yanaweza pelekea hata KIFO? Ni haki yako kushitaki (Report) madhara yoyote unayoyapata pindi unapotumia Dawa? Unaweza kushitaki makosa yaliyofanywa na mtaalamu wa Afya, akiwa anakupa matibabu?👇

    Prikaži ovu nit
  4. prije 2 sata

    One of the main stories this month is that EMA will require ICSR submissions in the ICH E2B(R3) format from 30-Jun-2022: Take a look inside our latest Intelligence Report and register for our monthly Free Updates !

  5. prije 2 sata

    Our end to end approach to medical literature monitoring for 💊🔍 can improve regulatory compliance and reduce the risk of missing alerts. Take a look at how we do it:

  6. DSRU Consultancy provides a special price-capped package for smaller companies. Our expert team provides one-off or ongoing advice on risk minimisation & risk management. World class science at a not for profit price!

  7. prije 5 sati

    How is Oracle Argus Safety used in Pharmacovigilance? Join our Oracle Argus Safety Faculty for a webinar tomorrow on Friday, 7th February at 10am EST/ 8:30pm IST. Register for the Webinar at

  8. prije 6 sati

    IQVIA Integrated Global Compliance's Joe Rymsza shares insights on , safety and regulatory trends and the use of advanced technologies in 2020 in Contract Pharma:

  9. Pulling out info from social media remains challenging – that's why UMC scientists & collaborators decided to sift through Twitter and develop a reference dataset of adverse event tweets. Read more in our new publication:

  10. prije 17 sati

    💼 Lundbeck - Graduate Patient Insights ❗️ Deadline: 09/02/2020 📊 Career level: Entry level (Graduate) and Junior 📍 Copenhagen 💬 Language(s): 🇬🇧 (fluent) ℹ️

  11. prije 17 sati

    Outsourcing services normally provided by affiliate offices is cost-effective & give you access to a network of local & global experts adaptable to your & . Download our whitepaper to learn more

  12. prije 23 sata

    To learn how to raise the bar with real-time surveillance, register for our upcoming this Thursday, February 6th!

  13. 5. velj

    We now know the decision-making criteria for our trials before we even recruit patients, and we have plans in place to adapt over 80 percent of our early phase trials

  14. Turacoz Skill Development Program conducted an Interactive Session on ‘Medical Communication Company Expectations from the Freshers’ at SGT University, Gurugram, India. .

  15. The ICSR, our main source of safety signals, is far from dead, say the authors of a commentary in Clinical Pharmacology & Therapeutics — but it can and should be improved. Read their predictions for in 2030 here:

  16. 4. velj

    Dysmech Clinical Services Pvt ltd offers a 6-month Diploma program in and with hands-on software training in Argus/ ARISg/ MedDRA in association with Drug Information with assured placement support all over India.

  17. 4. velj

    21st 2020! There will be a panel discussion on PV Audit & Inspections Knowing what is to be done. Moderator: Susan Welsh Panellists : Franck Schwartz Natalie Springveld Tea Babić

  18. 4. velj

    Do you want to know who is speaking at our 21st 2020. Check out here! Susan Welsh Chetan Shatapathy Valentina Mancini Sandy Eisen Panel Title: Brexit Implications for the UK –Impacts on PV

  19. 4. velj

    We are glad to introduce Moderator and Panelists for 21st 2020 Title: Quality, Safety & Signal Detection- Future of 2020 Moderator: Susan Welsh Panellists: John Poustie Mircea Ciuca Yvonne Nanciu Maddalena Lino

  20. 4. velj

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.